AssetMark Inc’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.53M | Sell |
61,765
-9,225
| -13% | -$677K | 0.01% | 606 |
|
|
2025
Q1 | $8.11M | Buy |
70,990
+14,413
| +25% | +$1.65M | 0.02% | 396 |
|
|
2024
Q4 | $2.85M | Sell |
56,577
-6,734
| -11% | -$339K | 0.01% | 634 |
|
|
2024
Q3 | $2.93M | Buy |
63,311
+1,235
| +2% | +$57.2K | 0.01% | 570 |
|
|
2024
Q2 | $2.02M | Buy |
62,076
+5,100
| +9% | +$166K | 0.01% | 615 |
|
|
2024
Q1 | $1.44M | Buy |
56,976
+875
| +2% | +$22K | ﹤0.01% | 648 |
|
|
2023
Q4 | $1.82M | Buy |
56,101
+38,674
| +222% | +$1.26M | 0.01% | 551 |
|
|
2023
Q3 | $475K | Sell |
17,427
-27,149
| -61% | -$740K | ﹤0.01% | 763 |
|
|
2023
Q2 | $992K | Buy |
44,576
+2,561
| +6% | +$57K | ﹤0.01% | 613 |
|
|
2023
Q1 | $910K | Buy |
42,015
+3,325
| +9% | +$72K | ﹤0.01% | 617 |
|
|
2022
Q4 | $786K | Buy |
38,690
+1,089
| +3% | +$22.1K | ﹤0.01% | 633 |
|
|
2022
Q3 | $964K | Buy |
37,601
+620
| +2% | +$15.9K | ﹤0.01% | 519 |
|
|
2022
Q2 | $879K | Buy |
36,981
+3,390
| +10% | +$80.6K | ﹤0.01% | 525 |
|
|
2022
Q1 | $756K | Sell |
33,591
-4,215
| -11% | -$94.9K | ﹤0.01% | 537 |
|
|
2021
Q4 | $749K | Sell |
37,806
-26,068
| -41% | -$516K | ﹤0.01% | 464 |
|
|
2021
Q3 | $1.26M | Buy |
63,874
+6,315
| +11% | +$124K | 0.01% | 374 |
|
|
2021
Q2 | $1.27M | Buy |
57,559
+29,258
| +103% | +$644K | 0.01% | 363 |
|
|
2021
Q1 | $673K | Buy |
28,301
+2,258
| +9% | +$53.7K | ﹤0.01% | 409 |
|
|
2020
Q4 | $681K | Sell |
26,043
-21,540
| -45% | -$563K | ﹤0.01% | 393 |
|
|
2020
Q3 | $828K | Buy |
47,583
+38,501
| +424% | +$670K | 0.01% | 348 |
|
|
2020
Q2 | $153K | Buy |
+9,082
| New | +$153K | ﹤0.01% | 526 |
|